We are live on ! Find out more
ICM

Invenomic Capital Management Portfolio holdings

AUM $2.18B
1-Year Est. Return 0.03%
This Fund
S&P 500
This Quarter Est. Return
+28.15%
1 Year Est. Return
+0.03%
3 Year Est. Return
-6.37%
5 Year Est. Return
-25.27%
10 Year Est. Return
AUM
$448M
AUM Growth
+$56.1M
Cap. Flow
+$34.8M
Cap. Flow %
7.76%
Top 10 Hldgs %
58.47%
Holding
175
New
33
Increased
39
Reduced
41
Closed
56

Top Buys

Rank Stock Value
1
CIVI
Civitas Resources
CIVI
+$3.77M
2
CNC icon
Centene
CNC
+$3.66M
3
DIN icon
Dine Brands
DIN
+$3.44M
4
LMT icon
Lockheed Martin
LMT
+$3.21M
5
FE icon
FirstEnergy
FE
+$2.65M

Sector Composition

Rank Sector Weight
1 Industrials 7.42%
2 Financials 6.92%
3 Consumer Discretionary 6.46%
4 Materials 5.99%
5 Healthcare 4.68%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SBH icon
51
Sally Beauty Holdings
SBH
$1.54B
$1.67M 0.37%
83,126
-13,533
-14% -$226K
VHI icon
52
Valhi
VHI
$473M
$1.67M 0.37%
81,557
+19,985
+32% +$371K
LEXX icon
53
Lexaria Bioscience
LEXX
$8.86M
$1.66M 0.37%
+19,740
New +$1.73M
LUMN icon
54
Lumen
LUMN
$6.82B
$1.64M 0.37%
+123,148
New +$1.53M
GRA
55
DELISTED
W.R. Grace & Co.
GRA
$1.6M 0.36%
26,738
-3,211
-11% -$192K
T icon
56
AT&T
T
$164B
$1.59M 0.36%
69,627
-10,151
-13% -$224K
C icon
57
Citigroup
C
$226B
$1.59M 0.35%
21,820
-2,568
-11% -$171K
HLF icon
58
Herbalife
HLF
$1.23B
$1.5M 0.34%
+33,928
New +$1.67M
KGC icon
59
CALL
Kinross Gold
KGC
$32.5B
$1.48M 0.33%
221,900
-527,600
-70% -$3.67M
RLGT icon
60
Radiant Logistics
RLGT
$390M
$1.47M 0.33%
211,597
+62,754
+42% +$415K
GCO icon
61
Genesco
GCO
$430M
$1.45M 0.32%
30,614
-37,874
-55% -$1.63M
HBB icon
62
Hamilton Beach Brands
HBB
$436M
$1.45M 0.32%
79,824
+46,374
+139% +$843K
PRTH icon
63
Priority Technology Holdings
PRTH
$432M
$1.4M 0.31%
201,145
-237
-0.1% -$1.85K
PLPC icon
64
Preformed Line Products
PLPC
$2.31B
$1.37M 0.3%
19,877
AD
65
Array Digital Infrastructure
AD
$3.05B
$1.26M 0.28%
+34,693
New +$1.15M
HRTG icon
66
Heritage Insurance Holdings
HRTG
$975M
$1.26M 0.28%
113,482
+18,700
+20% +$195K
ORCL icon
67
Oracle
ORCL
$437B
$1.25M 0.28%
+17,845
New +$1.16M
LUMN icon
68
CALL
Lumen
LUMN
$6.82B
$1.22M 0.27%
91,100
-239,400
-72% -$2.97M
CNR
69
DELISTED
Cornerstone Building Brands, Inc.
CNR
$1.21M 0.27%
86,297
+5,218
+6% +$63.2K
TEN
70
DELISTED
Tenneco Inc. Class A Voting Common Stock
TEN
$1.16M 0.26%
108,474
+68,311
+170% +$747K
TGLS icon
71
Tecnoglass Holdings Inc.
TGLS
$1.85B
$1.11M 0.25%
+92,289
New +$760K
SRTS icon
72
Sensus Healthcare
SRTS
$50.7M
$1.1M 0.25%
288,202
-15,564
-5% -$63.9K
VYX icon
73
NCR Voyix
VYX
$1.12B
$1.1M 0.25%
47,215
-85,410
-64% -$1.88M
IRIX icon
74
IRIDEX
IRIX
$15.1M
$1.07M 0.24%
159,045
-341,772
-68% -$1.97M
ADEA icon
75
Adeia
ADEA
$3.08B
$1.06M 0.24%
185,001
-283,375
-61% -$1.63M

Similar funds

Invenomic Capital Management's Q1 2021 Portfolio in Review

As of Q1 2021, Invenomic Capital Management held 175 positions worth $448M, up 14% from $392M the previous quarter. Its ten largest holdings account for 58% of the portfolio.

Invenomic Capital Management deployed $34.8M of net new capital in Q1 2021, opening 33 new positions and adding to 39 existing holdings. Its largest new stake was Centene: 59,072 shares worth $3.78M.

By sector, the portfolio is most concentrated in Industrials at 7.4% of assets, up from 6.8% a quarter earlier, followed by Financials and Consumer Discretionary.

On the sell side, the largest reduction was Discovery, Inc. Series C Common Stock, an estimated $3.37M trimmed.

  • Invenomic Capital Management's largest Q1 2021 buy was Centene: 59,072 shares worth $3.78M.
  • Invenomic Capital Management added most to Civitas Resources in Q1 2021, an estimated $3.77M increase.
  • Invenomic Capital Management's biggest Q1 2021 reduction was Discovery, Inc. Series C Common Stock, cutting an estimated $3.37M.
  • Invenomic Capital Management fully exited Heidrick & Struggles in Q1 2021, selling an estimated $4.62M.
  • Invenomic Capital Management's ten largest holdings make up 58% of its $448M portfolio in Q1 2021.
  • Invenomic Capital Management opened 33 new positions and closed 56 in Q1 2021.
  • Invenomic Capital Management's portfolio value rose 14% quarter-over-quarter to $448M.

Based on Invenomic Capital Management's 13F filing for Q1 2021, filed 13 May 2021.